- 10:36 AM Gems, jewellery industry seeks changes in Direct T...
- 10:36 AM Reliance Industries slips after ex-bonus
- 10:29 AM BSE launches FASTRADE™ - a new market access platf...
- 10:28 AM Microsoft tool to break the language barrier
- 10:26 AM Asian Hotels Jul-Sept qrtr net profit down at Rs 0...
- 10:16 AM Swiss court grants Roman Polanski bail
- 10:10 AM Karvy Stock Broking sees Dec series to be quite du...
- 10:04 AM Mahindra Satyam loses further ground
- 09:58 AM Zensar Technologies has target of Rs 323: Gujral
- 09:57 AM Sensex choppy with negative bias; RIL goes ex-bonu...



Ranbaxy Laboratories Limited (Ranbaxy) and Orchid Chemicals & Pharmaceuticals Limited (Orchid) today announced that they have entered into a Business Alliance Agreement involving multiple geographies and therapies for both finished dosage formulations and active pharmaceutical ingredients. Additionally, this agreement would establish a framework for enhanced future co-operation between the two companies.
Speaking on the development, Mr. Malvinder Mohan Singh, CEO & MD, Ranbaxy, said, "Orchid is a niche player in the global pharmaceutical industry with an impressive track record, particularly in sterile products. We are pleased to enter into this long term strategic alliance with Orchid. The agreement will be mutually beneficial and synergistic, allowing both organisations to leverage each others inherent strengths."
Commenting on the alliance, Mr. K. Raghavendra Rao, Managing Director, Orchid, said, "We are happy to join hands with Ranbaxy, India's largest pharmaceutical company. Ranbaxy's global scale and market reach and Orchid's state-of-the-art development and manufacturing capabilities would expand the business of both companies. We believe that this will be a win-win arrangement for both companies”
Sourced From: Ranbaxy Laboratories Ltd
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Expert stock/sector picks in these markets

- US to face stimulus aftershocks: Warren Buffett
- India to sell $70 bn shares in 3 years: Morgan Stanley
- Sell Mahindra Satyam: Sandeep Wagle

- Mkts to remain strong; bet on midcaps: Ramesh Damani
- Mahindra Satyam to declare audited nos by June 2010

- Mahindra Satyam has good support at Rs 88: Mohindar

- Nifty to test 5500 post 5-7% correction: JM Financial

- S&P raises fears over health of some banks
Source: ft.com
- Auto sector growth to push up demand for rubber
Source: Business Line
- High networth individuals see glitter in commodities
Source: Business Line
- Tatas may launch electric Indica by early 2011
Source: Business Line










